Remission of Ulcerative Colitis

Fourteen patients with mild to moderate ulcerative colitis consumed 200 to 300 billion B. longum BB536 together with a therapeutic agent for 24 weeks. The symptom scores decreased in 12 of the 14 patients, 10 of which achieved remission.

Changes in CAI scores (different affected regions) during B. longum BB536 administration
Q:What is ulcerative colitis?

This information is not intended for the final consumer. This is based on the research and our development work and is, to the best of our knowledge, reliable. However, Morinaga does not assume any liability or risk involved in the use of its final products, and Manufactures should check regulatory status of any claims according to the intended use of their products.